First Light Asset Management’s Epizyme, Inc EPZM Stock Holding History

First Light Asset Management’s Portfolio EPZM Stock Details EPZM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-195,160	Closed	-$3.03M	–	71
2020 Q1	$3.03M	Sell	195,160 -2,083	-1%	-$44.7K	0.52%	39
2019 Q4	$4.85M	Sell	197,243 -816	-0.4%	-$12.1K	0.62%	36
2019 Q3	$2.04M	Sell	198,059 -2,004	-1%	-$25.3K	0.31%	48
2019 Q2	$2.51M	Buy	+200,063	New	+$2.57M	0.35%	45

Other funds holding EPZM

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

RP Management New York $139M AUM 37.98% 1-Year Est. Return

Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return

First Light Asset Management's EPZM Position: Q2 2020 in Review

First Light Asset Management sold out of Epizyme, Inc (EPZM) in Q2 2020, closing a stake of 195,160 shares — an estimated $3.03M sold.

First Light Asset Management first reported a position in EPZM in Q2 2019 and held it in 4 quarters. The position peaked at $4.85M in Q4 2019. 160 funds tracked by Wall St. Rank hold EPZM as of Q2 2020.

First Light Asset Management reported no remaining Epizyme, Inc position as of Q2 2020 after selling out during the quarter.
First Light Asset Management sold 195,160 Epizyme, Inc shares in Q2 2020, an estimated $3.03M.
First Light Asset Management first reported a position in Epizyme, Inc in Q2 2019 and held it in 4 quarters.
First Light Asset Management's Epizyme, Inc position peaked at $4.85M in Q4 2019.
160 funds tracked by Wall St. Rank held Epizyme, Inc as of Q2 2020.

Based on First Light Asset Management's 13F filing for Q2 2020, filed 14 Aug 2020.